Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

[Advances of the relationship between leptin system and non-small cell lung cancer].

Wei T, Lu L, Shen Q, Fang C.

Zhongguo Fei Ai Za Zhi. 2014 Apr;17(4):347-50. doi: 10.3779/j.issn.1009-3419.2014.04.10. Review. Chinese.

2.

Hepatoma cell-derived leptin downregulates the immunosuppressive function of regulatory T-cells to enhance the anti-tumor activity of CD8+ T-cells.

Wei R, Hu Y, Dong F, Xu X, Hu A, Gao G.

Immunol Cell Biol. 2016 Apr;94(4):388-99. doi: 10.1038/icb.2015.110. Epub 2015 Dec 7.

PMID:
26639061
3.

Role of dysregulated expression of leptin and leptin receptors in colorectal carcinogenesis.

Uddin S, Hussain AR, Khan OS, Al-Kuraya KS.

Tumour Biol. 2014 Feb;35(2):871-9. doi: 10.1007/s13277-013-1166-4. Epub 2013 Sep 7. Review.

PMID:
24014051
4.

Loss of phosphatase and tensin homolog (PTEN) induces leptin-mediated leptin gene expression: feed-forward loop operating in the lung.

Pathak RR, Grover A, Malaney P, Quarni W, Pandit A, Allen-Gipson D, Davé V.

J Biol Chem. 2013 Oct 11;288(41):29821-35. doi: 10.1074/jbc.M113.481523. Epub 2013 Aug 20.

5.

Evidence of an autocrine role for leptin and leptin receptor in human breast cancer.

Wazir U, Al Sarakbi W, Jiang WG, Mokbel K.

Cancer Genomics Proteomics. 2012 Nov;9(6):383-7.

PMID:
23162077
6.

[Current status of Akt in non-small cell lung cancer].

Chen B, Li W.

Zhongguo Fei Ai Za Zhi. 2010 Nov;13(11):1059-63. doi: 10.3779/j.issn.1009-3419.2010.11.12. Review. Chinese.

7.

CHIP involves in non-small cell lung cancer prognosis through VEGF pathway.

Tingting Q, Jiao W, Qingfeng W, Yancheng L, Shijun YU, Zhaoqi W, Dongmei S, ShiLong W.

Biomed Pharmacother. 2016 Oct;83:271-276. doi: 10.1016/j.biopha.2016.06.015. Epub 2016 Jul 5.

PMID:
27392029
8.

Defective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis.

Taleb S, Herbin O, Ait-Oufella H, Verreth W, Gourdy P, Barateau V, Merval R, Esposito B, Clément K, Holvoet P, Tedgui A, Mallat Z.

Arterioscler Thromb Vasc Biol. 2007 Dec;27(12):2691-8. Epub 2007 Aug 9.

9.

Hypoxia-inducible factor 1α (HIF-1α) and reactive oxygen species (ROS) mediates radiation-induced invasiveness through the SDF-1α/CXCR4 pathway in non-small cell lung carcinoma cells.

Gu Q, He Y, Ji J, Yao Y, Shen W, Luo J, Zhu W, Cao H, Geng Y, Xu J, Zhang S, Cao J, Ding WQ.

Oncotarget. 2015 May 10;6(13):10893-907.

10.

miRNA-124 down-regulates SOX8 expression and suppresses cell proliferation in non-small cell lung cancer.

Xie C, Han Y, Liu Y, Han L, Liu J.

Int J Clin Exp Pathol. 2014 Sep 15;7(10):6534-42. eCollection 2014.

11.

miR-99a suppresses the metastasis of human non-small cell lung cancer cells by targeting AKT1 signaling pathway.

Yu SH, Zhang CL, Dong FS, Zhang YM.

J Cell Biochem. 2015 Feb;116(2):268-76. doi: 10.1002/jcb.24965.

PMID:
25187230
12.

Role of leptin and leptin receptors in hematological malignancies.

Uddin S, Mohammad RM.

Leuk Lymphoma. 2016;57(1):10-6. doi: 10.3109/10428194.2015.1063145. Epub 2015 Jul 7. Review.

PMID:
26077362
13.

Expression, prognostic and predictive impact of VEGF and bFGF in non-small cell lung cancer.

Farhat FS, Tfayli A, Fakhruddin N, Mahfouz R, Otrock ZK, Alameddine RS, Awada AH, Shamseddine A.

Crit Rev Oncol Hematol. 2012 Nov;84(2):149-60. doi: 10.1016/j.critrevonc.2012.02.012. Epub 2012 Apr 9. Review.

PMID:
22494932
14.

Expression of gamma-aminobutyric acid receptors on neoplastic growth and prediction of prognosis in non-small cell lung cancer.

Zhang X, Zhang R, Zheng Y, Shen J, Xiao D, Li J, Shi X, Huang L, Tang H, Liu J, He J, Zhang H.

J Transl Med. 2013 Apr 24;11:102. doi: 10.1186/1479-5876-11-102.

15.

Tumor-suppressive p53 Signaling Empowers Metastatic Inhibitor KLF17-dependent Transcription to Overcome Tumorigenesis in Non-small Cell Lung Cancer.

Ali A, Bhatti MZ, Shah AS, Duong HQ, Alkreathy HM, Mohammad SF, Khan RA, Ahmad A.

J Biol Chem. 2015 Aug 28;290(35):21336-51. doi: 10.1074/jbc.M114.635730. Epub 2015 Apr 24.

16.

Prostaglandin E2 upregulates β1 integrin expression via the E prostanoid 1 receptor/nuclear factor κ-light-chain-enhancer of activated B cells pathway in non-small-cell lung cancer cells.

Bai X, Yang Q, Shu W, Wang J, Zhang L, Ma J, Xia S, Zhang M, Cheng S, Wang Y, Leng J.

Mol Med Rep. 2014 May;9(5):1729-36. doi: 10.3892/mmr.2014.2000. Epub 2014 Feb 28.

PMID:
24584670
17.

miR141-CXCL1-CXCR2 signaling-induced Treg recruitment regulates metastases and survival of non-small cell lung cancer.

Lv M, Xu Y, Tang R, Ren J, Shen S, Chen Y, Liu B, Hou Y, Wang T.

Mol Cancer Ther. 2014 Dec;13(12):3152-62. doi: 10.1158/1535-7163.MCT-14-0448. Epub 2014 Oct 27.

18.

20 years of leptin: insights into signaling assemblies of the leptin receptor.

Peelman F, Zabeau L, Moharana K, Savvides SN, Tavernier J.

J Endocrinol. 2014 Oct;223(1):T9-23. doi: 10.1530/JOE-14-0264. Epub 2014 Jul 25. Review.

19.

Low expression of Mig-6 is associated with poor survival outcome in NSCLC and inhibits cell apoptosis via ERK-mediated upregulation of Bcl-2.

Li Z, Qu L, Zhong H, Xu K, Qiu X, Wang E.

Oncol Rep. 2014 Apr;31(4):1707-14. doi: 10.3892/or.2014.3050. Epub 2014 Feb 24.

PMID:
24573418
20.

Supplemental Content

Support Center